Coronavirus disease 2019 (COVID-19) monoclonal antibody treatments & products
Medicare Part B (Medical Insurance) covers FDA-authorized or approved COVID-19 monoclonal antibody treatments and products if you have COVID-19 symptoms.
Your costs in Original Medicare
You pay nothing for a monoclonal antibody treatment when you get it from a Medicare provider or supplier. You must meet certain conditions to qualify.
What it is
If you test positive for COVID-19 and have mild to moderate symptoms, these treatments can help fight the disease and keep you out of the hospital. This treatment involves an infusion of monoclonal antibodies (specifically bamlanivimab, or casirivimab and imdevimab) to treat COVID-19. Health care providers can only give the infusions in certain settings.
Things to know
Medicare also covers COVID-19 diagnostic tests, COVID-19 antibody tests, and COVID-19 vaccines.